Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Pope

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Arthritis Research & Therapy|September 27, 2023
Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abataceptLouis Bessette, Boulos Haraoui, Emmanouil Rampakakis, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 18, 2006
Nutritional status and food insecurity in hemodialysis patientsGloria Wilson, Elaine Fontenot Molaison, Janet Pope, et al.
Obesity Surgery|September 7, 2015
Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve GastrectomyLindsay B Adams, Craig Chang, Janet Pope, et al.
Journal of Clinical Medicine|February 4, 2021
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative ReviewPeter C Taylor, Fabiola Atzeni, Alejandro Balsa, et al.
Nature Reviews. Disease Primers|May 19, 2016
Systemic sclerosisYannick Allanore, Robert Simms, Oliver Distler, et al.
Rheumatology (Oxford, England)|October 20, 2019
An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDsJanet Pope, Emmanouil Rampakakis, Julie Vaillancourt, et al.
Arthritis Research & Therapy|March 8, 2012
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosisMarie Hudson, Janet Pope, Michael Mahler, et al.
Rheumatology (Oxford, England)|May 23, 2014
Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib studyJanet Pope, Kyle M Walker, Faye de Leon, et al.
The Journal of Rheumatology|June 3, 2009
Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysisKhulood Mohammed, Janet Pope, Nicole Le Riche, et al.
Rheumatology (Oxford, England)|December 21, 2010
Clinical correlates of sleep problems in systemic sclerosis: the prominent role of painKatherine Milette, Ilya Razykov, Janet Pope, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Arthritis Research & Therapy|September 27, 2023
Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abataceptLouis Bessette, Boulos Haraoui, Emmanouil Rampakakis, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 18, 2006
Nutritional status and food insecurity in hemodialysis patientsGloria Wilson, Elaine Fontenot Molaison, Janet Pope, et al.
Obesity Surgery|September 7, 2015
Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve GastrectomyLindsay B Adams, Craig Chang, Janet Pope, et al.
Journal of Clinical Medicine|February 4, 2021
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative ReviewPeter C Taylor, Fabiola Atzeni, Alejandro Balsa, et al.
Nature Reviews. Disease Primers|May 19, 2016
Systemic sclerosisYannick Allanore, Robert Simms, Oliver Distler, et al.
Rheumatology (Oxford, England)|October 20, 2019
An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDsJanet Pope, Emmanouil Rampakakis, Julie Vaillancourt, et al.
Arthritis Research & Therapy|March 8, 2012
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosisMarie Hudson, Janet Pope, Michael Mahler, et al.
Rheumatology (Oxford, England)|May 23, 2014
Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib studyJanet Pope, Kyle M Walker, Faye de Leon, et al.
The Journal of Rheumatology|June 3, 2009
Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysisKhulood Mohammed, Janet Pope, Nicole Le Riche, et al.
Rheumatology (Oxford, England)|December 21, 2010
Clinical correlates of sleep problems in systemic sclerosis: the prominent role of painKatherine Milette, Ilya Razykov, Janet Pope, et al.
Pageof 17